Biomarkers of Alzheimer’s disease: Past, present and future clinical use

Joanna E. Georgakas, Matthew D. Howe, Louisa I. Thompson, Natalie M. Riera, Meghan C. Riddle

Open source

DOI
10.1016/j.bionps.2023.100063
Published
06
Container
Biomarkers in Neuropsychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bionps.2023.100063,
  title = {Biomarkers of Alzheimer’s disease: Past, present and future clinical use},
  author = {Joanna E. Georgakas and Matthew D. Howe and Louisa I. Thompson and Natalie M. Riera and Meghan C. Riddle},
  year = {2023},
  journal = {Biomarkers in Neuropsychiatry},
  doi = {10.1016/j.bionps.2023.100063},
  url = {https://doi.org/10.1016/j.bionps.2023.100063}
}

RIS

TY  - JOUR
TI  - Biomarkers of Alzheimer’s disease: Past, present and future clinical use
AU  - Joanna E. Georgakas
AU  - Matthew D. Howe
AU  - Louisa I. Thompson
AU  - Natalie M. Riera
AU  - Meghan C. Riddle
PY  - 2023
JO  - Biomarkers in Neuropsychiatry
DO  - 10.1016/j.bionps.2023.100063
UR  - https://doi.org/10.1016/j.bionps.2023.100063
ER  - 

APA

Georgakas, J. E., Howe, M. D., Thompson, L. I., Riera, N. M., & Riddle, M. C. (2023). Biomarkers of Alzheimer’s disease: Past, present and future clinical use. Biomarkers in Neuropsychiatry. https://doi.org/10.1016/j.bionps.2023.100063

Source records